ArticleFrontiers in psychology2024
Emotional and visual responses to trypophobic images with object, animal, or human body backgrounds: an eye-tracking study.
Article in Frontiers in psychology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Trypophobia refers to the visual discomfort (e.g., disgust or anxiety) experienced by some people when viewing clusters of bumps or holes. The spectral profile framework suggests that the spectral components of clustered patterns induces trypophobia. In contrast, the cognitive framework speculates that cognitive appraisal of dangerous objects (e.g., ectoparasites) causes trypophobia. A background effect (e.g., more disgust toward trypophobic patterns on the skin than on a desk) seems to support the cognitive framework. However, there is no study providing objective evidence for that effect and verifying these frameworks at the same time. This study aims to address that limitation by psychometric and eye-tracking experiments. Methods: We recruited 183 participants from colleges. Initially, participants finished a personality questionnaire. The cohort then completed an eye-tracking experiment which showed the trypophobic pattern of lotus seed on three categories of background images (objects, animals and human bodies). Finally, participants rated the image's disgust and arousal levels using a self-assessment rating scale. Meanwhile, we compared all images' luminosity and power spectra. Results: Trypophobic images with the human body or animal backgrounds induced a higher level of disgust and arousal than those with the object backgrounds. Participants gazed faster and dwelled longer at the trypophobic patterns on human body images than on object or animal images. Furthermore, trypophobic images with human body or animal backgrounds induced more substantial pupil dilation than those upon object backgrounds. No significant difference was detected between the power of trypophobic images with human body backgrounds and objects backgrounds. As the trypophobic images with human body backgrounds induced significant emotional or visual responses compared to those with inanimate object backgrounds. Such inconsistent results imply that the differential emotional or visual responses to trypophobic images are probably not induced by the difference in power spectra. Finally, the disgust/arousal level toward trypophobic images did not correlate with personality traits. Conclusion: These results supported the background effect of trypophobia, namely, trypophobic images with animal or human body backgrounds induce more severe disgust and cause more arousal than those with object backgrounds. Our results support the cognitive, but not spectral profile, framework of trypophobia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.